Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$5.04 - $9.95 $60,480 - $119,399
12,000 New
12,000 $111,000
Q2 2023

Aug 14, 2023

SELL
$7.66 - $9.5 $21,448 - $26,600
-2,800 Reduced 47.46%
3,100 $25,000
Q1 2023

May 15, 2023

BUY
$8.32 - $11.75 $49,088 - $69,325
5,900 New
5,900 $50,000
Q1 2022

May 16, 2022

BUY
$9.74 - $17.69 $212,332 - $385,642
21,800 New
21,800 $268,000
Q4 2021

Feb 14, 2022

SELL
$16.88 - $23.31 $118,160 - $163,170
-7,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$16.82 - $25.75 $299,396 - $458,350
-17,800 Reduced 71.77%
7,000 $126,000
Q2 2021

Aug 16, 2021

BUY
$10.16 - $28.86 $251,968 - $715,728
24,800 New
24,800 $567,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $581M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.